clinical trial · NCT07654400
A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.·phase2·recruiting·n = 36
Extensive-stage Small-cell Lung CancerBL-M14D1Atezolizumab
brief summary
This Phase II study is a clinical study exploring the efficacy and safety of BL-M14D1 in combination with Atezolizumab in patients with extensive-stage small cell lung cancer.
started
Jul 9, 2026
primary completion
Dec 1, 2027
completion
Dec 1, 2027
last updated
Aug 25, 2026
official title
A Phase II Clinical Study to Evaluate the Efficacy and Safety of BL-M14D1 for Injection in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol